New treatment option for HIV Prevention
Official title Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
ClinicalTrials.gov ID: NCT07292584
What this study is testing
- What it's testing
- The goal of this study is to test if a Digital PrEP Toolkit helps cisgender women learn about and access PrEP in Alabama and Mississippi. PrEP is a medication that prevents HIV infection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- HIV-negative
- Cisgender women
- 18 years or older
- English-speaking
- Report sexual activity in the last six months or anticipate sexual activity in the next six months.
You likely can't join if
- Younger than 18 years of age
- Do not identify as female and/or were not biologically assigned female at birth
- Living with HIV
- Report no sexual activity in the past six months and no anticipated sexual activity in the next six months
- Unable or unwilling to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Montgomery, Alabama, United States
- Tuscaloosa, Alabama, United States
- Starkville, Mississippi, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Montgomery, Alabama, United States; Tuscaloosa, Alabama, United States; Starkville, Mississippi, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.